Haemonetics Corp. (MA) (HAE)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Christopher Simon
Employees:
3,216
400 WOOD RD, BRAINTREE, MA 02184
7818487100

Haemonetics Corp. operates as a global healthcare company, which engages in the provision of products for processing, handling, and analysis of blood. Its products are divided into four categories: Plasma, Blood Center, Hospital, and Software Solutions. The Plasma product line includes plasma collection market for fractionation and the company's plasma products. The Blood Center product line offers blood collection market for transfusion and the company's blood center products. The Hospital product line provides transfusion market for hospitals and the company's hospital products. The Software Solutions deals with the software products and services. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Braintree, MA.

Data derived from most recent annual or quarterly report
Market Cap 3.384 Billion Shares Outstanding51.299 Million Avg 30-day Volume 465.763 Thousand
P/E Ratio72.3144 Dividend Yield0.0 EPS1.27
Price to Revenue6.602 Debt to Equity0.9671 EBITDA157.764 Million
Price to Book Value7.8543 Operating Margin10.3103 Enterprise Value6.262 Billion
Current Ratio2.736 EPS Growth0.047 Quick Ratio1.262
1 Yr BETA 0.9098 52-week High/Low 75.34 / 43.5 Profit Margin9.1295
Operating Cash Flow Growth-31.2305 Altman Z-Score4.1906 Free Cash Flow to Firm -316.865 Million
Earnings Report2022-08-10
View SEC Filings from HAE instead.

View recent insider trading info

Haemonetics Corp. (MA) YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding HAE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HAE BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2022-06-15 by MILLER LAURIE A.
  • 4: filed on 2022-06-15 by GOLDSTEIN DAN
  • 4: filed on 2022-06-15 by BASIL MICHELLE L
  • 4: filed on 2022-06-15 by SIMON, CHRISTOPHER
  • 4: filed on 2022-06-06 by GOLDSTEIN DAN
  • 4: filed on 2022-06-06 by MILLER LAURIE A.
  • 4: filed on 2022-05-23 by STRONG STEWART W
  • 4: filed on 2022-05-23 by SIMON, CHRISTOPHER
  • 4: filed on 2022-05-23 by MILLER LAURIE A.
  • 4: filed on 2022-05-23 by LLORENS JOSEP

    • Events (8k)

  • 8-K: filed on 2022-06-16:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-05-25:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-05-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-21:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-15:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2022-02-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-09:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2021-05-21:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    13 Thousand total shares from 18 transactions

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SIMON, CHRISTOPHER PRESIDENT & CEO

    • Officer
    • Director
    		 213,724 2022-06-13 3

    BASIL MICHELLE L EVP AND GENERAL COUNSEL

    • Officer
    		 40,635 2022-06-13 4

    GOLDSTEIN DAN VP, CORPORATE CONTROLLER

    • Officer
    		 4,447 2022-06-13 4

    MILLER LAURIE A. SVP, HUMAN RESOURCES

    • Officer
    		 12,951 2022-06-13 7

    STRONG STEWART W PRESIDENT, GLOBAL HOSPITAL

    • Officer
    		 15,756 2022-05-19 4

    LLORENS JOSEP EVP, GLOBAL MANUFACTURING

    • Officer
    		 17,335 2022-05-19 3

    LINGAMNENI ANILA EVP, CHIEF TECHNOLOGY OFFICER

    • Officer
    		 17,322 2022-05-19 3

    DARECCA JAMES EVP, CHIEF FINANCIAL OFFICER

    • Officer
    		 21,839 2022-05-16 3

    BURKE WILLIAM P. MR. EVP, CHIEF FINANCIAL OFFICER

    • Officer
    		 30,291 2021-08-23 2

    ABERNATHY ROBERT E

    • Director
    		 15,125 2021-08-06 1

    COYLE MICHAEL J

    • Director
    		 5,538 2021-08-06 1

    KROLL MARK W

    • Director
    		 21,517 2021-08-06 1

    BURZIK CATHERINE M

    • Director
    		 16,815 2021-08-06 1

    ZANE ELLEN M

    • Director
    		 9,517 2021-08-06 1

    DOCKENDORFF CHARLES J

    • Director
    		 25,400 2021-08-06 1

    POMEROY CLAIRE

    • Director
    		 7,016 2021-08-06 1

    JOHNSON LLOYD EMERSON

    • Director
    		 0 2021-08-06 2

    NIKEL CHAD M. PRESIDENT, GLOBAL PLASMA & BC

    • Officer
    		 17,336 2021-08-06 1

    SCANLAN JACQUELINE SVP, GLOBAL HUMAN RESOURCES

    • Officer
    		 4,216 2021-06-07 0

    MEELIA RICHARD J

    • Director
    		 32,050 2021-02-04 0

    GELBMAN RONALD G

    • Director
    		 48,384 2019-11-11 0

    BOLORFOROSH SAID EVP, CHIEF TECHNOLOGY OFFICER

    • Officer
    		 1,977 2019-11-11 0

    GRANADILLO PEDRO P

    • Director
    		 15,335 2018-11-08 0

    RYDING NEIL MR. EVP, GLOBAL MANUFACTURING

    • Officer
    		 15,226 2018-06-07 0

    FOOTE SUSAN BARTLETT

    • Director
    		 20,740 2017-11-10 0

    MERRIMAN RONALD

    • Director
    		 17,807 2017-05-22 0

    JESSE SANDRA EVP AND CHIEF LEGAL OFFICER

    • Officer
    		 48,166 2016-10-25 0

    SELMAN BYRON PRESIDENT, GLOBAL MARKETS

    • Officer
    		 23,318 2016-10-25 0

    FUSCO DAVID EVP, GLOBAL HUMAN RESOURCES

    • Officer
    		 16,867 2016-10-25 0

    LINDOP CHRISTOPHER J CFO & EVP BUSINESS DEVELOPMENT

    • Officer
    		 56,743 2016-01-13 0

    HANLON SUSAN M VP FINANCE

    • Officer
    		 20,464 2015-10-26 0

    WHITE JONATHAN CHIEF SCIENCE AND TECHNOLOGY

    • Officer
    		 30,507 2015-10-26 0

    BURNS BRIAN R EVP, GLOBAL QA/RA

    • Officer
    		 16,235 2015-10-23 0

    DAVIES KENT J CHIEF OPERATING OFFICER

    • Officer
    		 16,891 2015-10-23 0

    CONCANNON BRIAN PRESIDENT & CEO

    • Officer
    • Director
    		 147,040 2015-09-15 0

    ALLEN PETER M PRESIDENT, GLOBAL PLASMA

    • Officer
    		 34,102 2015-07-06 0

    HELSEL DAVE EVP, GLOBAL MANUFACTURING

    • Officer
    		 13,216 2015-04-13 0

    MCDANIEL KATHLEEN EVP GLOBAL HUMAN RESOURCES

    • Officer
    		 5,013 2014-08-28 0

    BEST LAWRENCE C

    • Director
    		 10,001 2014-06-12 0

    KELLY MICHAEL P PRESIDENT, GLOBAL MARKETS

    • Officer
    		 10,987 2013-11-11 0

    NIGHAN WARREN JR EVP, GLOBAL QA/RA

    • Officer
    		 7,618 2013-07-24 0

    BLACK PAUL

    • Director
    		 8,981 2013-07-24 0

    FORISH JOSEPH J VP, HUMAN RESOURCES

    • Officer
    		 162,747 2013-04-30 0

    GORDON MIKAEL PRESIDENT, GLOBAL MARKETS

    • Officer
    		 4,442 2012-05-03 0

    BRANCAZIO PHILLIP JOHN VP, GLOBAL MANUFACTURING

    • Officer
    		 38,572 2011-05-04 0

    LOPEZ ALICIA R VP, CORPORATE AFFAIRS

    • Officer
    		 2,915 2011-04-05 0

    RUXIN MICHAEL I VP GLOBAL SOFTWARE STRATEGIES

    • Officer
    • VP GLOBAL SOFTWARE STRATEGIES
    		 215 2010-11-04 0

    NUTTER BRAD CHAIRMAN OF THE BOARD

    • Officer
    • Director
    		 10,580 2010-07-29 0

    EBBELING ROBERT B VICE PRESIDENT, OPERATIONS

    • Officer
    		 123,405 2009-05-01 0

    PARE ANTHONY

    • VP & GEN MGR, SERVICES BUSINES
    		 2,523 2008-06-30 0

    BEUCLER MARK

    • VP & GMGLOBAL DISTRIB CHAN MNG
    		 35,602 2008-05-01 0

    SWENSON STEPHEN VP & GENERAL MGR, GLOBAL PLASM

    • Officer
    		 161,364 2008-05-01 0

    POPOVSKY MARK A VP, CORPORATE MEDICAL DIRECTOR

    • Officer
    		 76,463 2008-05-01 0

    GRANVILLE WILLIAM VP, MANUFACTURING

    • Officer
    		 73,366 2008-05-01 0

    HATTORI KEIKO PRESIDENT, HAEMONETICS JAPAN

    • Officer
    		 10,156 2008-05-01 0

    CONNEELY JAN VP & GM, ARRYX, INC.

    • Officer
    		 12,840 2008-05-01 0

    O'SHAUGHNESSY JAMES

    • VP, GENERAL COUNSEL
    		 46,246 2008-05-01 0

    SAKAI RYOJI PRESIDENT, JAPAN

    • Officer
    		 28,373 2007-06-14 0

    STILL WILLIAM ROCHE VP & GEN MRG, THERAPEUTICS BUS

    • Officer
    		 86,084 2007-05-01 0

    RYAN RONALD J VP AND CFO

    • Officer
    		 83,622 2006-08-10 0

    ECKERT ULRICH PRESIDENT, EUROPE & LATIN AM

    • Officer
    		 107,375 2006-06-20 0

    MATRICARIA RONALD A

    • Director
    		 37,000 2006-05-05 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    BASIL MICHELLE L - Officer EVP AND GENERAL COUNSEL

    		2022-06-15 16:29:24 -0400 2022-06-13 S 277 $62.60 d 40,635 direct 2.5135 10.0877 10.0877 6 0.0 1

    MILLER LAURIE A. - Officer SVP, HUMAN RESOURCES

    		2022-06-15 16:34:02 -0400 2022-06-13 S 30 $62.60 d 12,951 direct 2.5135 10.0877 10.0877 6 0.0 1

    GOLDSTEIN DAN - Officer VP, CORPORATE CONTROLLER

    		2022-06-15 16:31:59 -0400 2022-06-13 S 42 $62.60 d 4,447 direct 2.5135 10.0877 10.0877 6 0.0 1

    SIMON, CHRISTOPHER - Director - Officer PRESIDENT & CEO

    		2022-06-15 16:27:05 -0400 2022-06-13 S 1,148 $62.60 d 213,724 direct 2.5135 10.0877 10.0877 6 0.0 1

    GOLDSTEIN DAN - Officer VP, CORPORATE CONTROLLER

    		2022-06-06 16:28:32 -0400 2022-06-02 S 249 $62.69 d 4,489 direct -0.7264 -5.7203 0.0 1 -5.7203 6

    MILLER LAURIE A. - Officer SVP, HUMAN RESOURCES

    		2022-06-06 16:24:12 -0400 2022-06-02 S 198 $62.69 d 12,981 direct -0.7264 -5.7203 0.0 1 -5.7203 6

    STRONG STEWART W - Officer PRESIDENT, GLOBAL HOSPITAL

    		2022-05-23 16:18:23 -0400 2022-05-19 S 1,084 $59.10 d 15,756 direct 2.9126 2.5012 5.5784 4 0.0 1

    BASIL MICHELLE L - Officer EVP AND GENERAL COUNSEL

    		2022-05-23 16:08:06 -0400 2022-05-19 S 3,258 $59.10 d 40,912 direct 2.9126 2.5012 5.5784 4 0.0 1

    GOLDSTEIN DAN - Officer VP, CORPORATE CONTROLLER

    		2022-05-23 16:10:26 -0400 2022-05-19 S 134 $59.10 d 4,738 direct 2.9126 2.5012 5.5784 4 0.0 1

    LINGAMNENI ANILA - Officer EVP, CHIEF TECHNOLOGY OFFICER

    		2022-05-23 16:12:56 -0400 2022-05-19 S 1,384 $59.10 d 17,322 direct 2.9126 2.5012 5.5784 4 0.0 1

    MILLER LAURIE A. - Officer SVP, HUMAN RESOURCES

    		2022-05-23 16:15:58 -0400 2022-05-19 S 91 $59.10 d 13,179 direct 2.9126 2.5012 5.5784 4 0.0 1

    SIMON, CHRISTOPHER - Director - Officer PRESIDENT & CEO

    		2022-05-23 16:17:08 -0400 2022-05-19 S 2,496 $59.10 d 214,872 direct 2.9126 2.5012 5.5784 4 0.0 1

    LLORENS JOSEP - Officer EVP, GLOBAL MANUFACTURING

    		2022-05-23 16:14:13 -0400 2022-05-19 S 1,418 $59.10 d 17,335 direct 2.9126 2.5012 5.5784 4 0.0 1

    MILLER LAURIE A. - Officer SVP, HUMAN RESOURCES

    		2022-05-18 17:10:05 -0400 2022-05-16 S 31 $56.10 d 10,232 direct -1.4127 3.4901 3.9388 5 -1.4127 2

    STRONG STEWART W - Officer PRESIDENT, GLOBAL HOSPITAL

    		2022-05-18 17:13:30 -0400 2022-05-16 A 9,641 a 9,641 direct

    STRONG STEWART W - Officer PRESIDENT, GLOBAL HOSPITAL

    		2022-05-18 17:13:30 -0400 2022-05-16 A 4,123 a 16,840 direct -1.4127 3.4901 3.9388 5 -1.4127 2

    MILLER LAURIE A. - Officer SVP, HUMAN RESOURCES

    		2022-05-18 17:10:05 -0400 2022-05-16 A 7,104 a 7,104 direct

    MILLER LAURIE A. - Officer SVP, HUMAN RESOURCES

    		2022-05-18 17:10:05 -0400 2022-05-16 A 3,038 a 13,270 direct -1.4127 3.4901 3.9388 5 -1.4127 2

    LLORENS JOSEP - Officer EVP, GLOBAL MANUFACTURING

    		2022-05-18 17:01:46 -0400 2022-05-16 A 10,148 a 10,148 direct

    SIMON, CHRISTOPHER - Director - Officer PRESIDENT & CEO

    		2022-05-18 16:26:46 -0400 2022-05-16 S 832 $56.10 d 191,327 direct -1.4127 3.4901 3.9388 5 -1.4127 2

    SIMON, CHRISTOPHER - Director - Officer PRESIDENT & CEO

    		2022-05-18 16:26:46 -0400 2022-05-16 A 26,041 a 217,368 direct -1.4127 3.4901 3.9388 5 -1.4127 2

    SIMON, CHRISTOPHER - Director - Officer PRESIDENT & CEO

    		2022-05-18 16:26:46 -0400 2022-05-16 A 60,891 a 60,891 direct

    DARECCA JAMES - Officer EVP, CHIEF FINANCIAL OFFICER

    		2022-05-18 16:34:44 -0400 2022-05-16 A 4,774 a 10,676 direct -1.4127 3.4901 3.9388 5 -1.4127 2

    DARECCA JAMES - Officer EVP, CHIEF FINANCIAL OFFICER

    		2022-05-18 16:34:44 -0400 2022-05-16 A 11,163 a 11,163 direct

    BASIL MICHELLE L - Officer EVP AND GENERAL COUNSEL

    		2022-05-18 16:40:47 -0400 2022-05-16 S 196 $56.10 d 38,094 direct -1.4127 3.4901 3.9388 5 -1.4127 2

    BASIL MICHELLE L - Officer EVP AND GENERAL COUNSEL

    		2022-05-18 16:40:47 -0400 2022-05-16 A 6,076 a 44,170 direct -1.4127 3.4901 3.9388 5 -1.4127 2

    BASIL MICHELLE L - Officer EVP AND GENERAL COUNSEL

    		2022-05-18 16:40:47 -0400 2022-05-16 A 14,208 a 14,208 direct

    GOLDSTEIN DAN - Officer VP, CORPORATE CONTROLLER

    		2022-05-18 16:53:12 -0400 2022-05-16 S 50 $56.10 d 4,004 direct -1.4127 3.4901 3.9388 5 -1.4127 2

    GOLDSTEIN DAN - Officer VP, CORPORATE CONTROLLER

    		2022-05-18 16:53:12 -0400 2022-05-16 A 868 a 4,872 direct -1.4127 3.4901 3.9388 5 -1.4127 2

    GOLDSTEIN DAN - Officer VP, CORPORATE CONTROLLER

    		2022-05-18 16:53:12 -0400 2022-05-16 A 2,029 a 2,029 direct

    LINGAMNENI ANILA - Officer EVP, CHIEF TECHNOLOGY OFFICER

    		2022-05-18 16:57:56 -0400 2022-05-16 A 4,340 a 18,706 direct -1.4127 3.4901 3.9388 5 -1.4127 2

    LINGAMNENI ANILA - Officer EVP, CHIEF TECHNOLOGY OFFICER

    		2022-05-18 16:57:56 -0400 2022-05-16 A 10,148 a 10,148 direct

    LLORENS JOSEP - Officer EVP, GLOBAL MANUFACTURING

    		2022-05-18 17:01:46 -0400 2022-05-16 S 107 $56.10 d 14,413 direct -1.4127 3.4901 3.9388 5 -1.4127 2

    LLORENS JOSEP - Officer EVP, GLOBAL MANUFACTURING

    		2022-05-18 17:01:46 -0400 2022-05-16 A 4,340 a 18,753 direct -1.4127 3.4901 3.9388 5 -1.4127 2

    DARECCA JAMES - Officer EVP, CHIEF FINANCIAL OFFICER

    		2022-05-04 16:41:13 -0400 2022-05-02 A 5,902 a 5,902 direct 1.5662 1.9969 18.9702 29.3657 23 -3.5435 3

    DARECCA JAMES - Officer EVP, CHIEF FINANCIAL OFFICER

    		2022-05-04 16:41:13 -0400 2022-05-02 A 13,828 a 13,828 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    HAEMONETICS CORP-MASS HAE 2022-06-30 22:15:03 UTC 1.1402 0.4298 1500000
    HAEMONETICS CORP-MASS HAE 2022-06-30 21:45:03 UTC 1.1402 0.4298 1500000
    HAEMONETICS CORP-MASS HAE 2022-06-30 21:15:03 UTC 1.1402 0.4298 1500000
    HAEMONETICS CORP-MASS HAE 2022-06-30 20:45:03 UTC 1.1402 0.4298 1500000
    HAEMONETICS CORP-MASS HAE 2022-06-30 20:15:04 UTC 1.1402 0.4298 1500000
    HAEMONETICS CORP-MASS HAE 2022-06-30 19:45:03 UTC 1.1402 0.4298 1500000
    HAEMONETICS CORP-MASS HAE 2022-06-30 19:15:03 UTC 1.1402 0.4298 1500000
    HAEMONETICS CORP-MASS HAE 2022-06-30 18:45:04 UTC 1.1402 0.4298 1500000
    HAEMONETICS CORP-MASS HAE 2022-06-30 18:15:04 UTC 1.1402 0.4298 1500000
    HAEMONETICS CORP-MASS HAE 2022-06-30 17:45:03 UTC 1.1402 0.4298 1500000
    HAEMONETICS CORP-MASS HAE 2022-06-30 17:15:03 UTC 1.1402 0.4298 1500000
    HAEMONETICS CORP-MASS HAE 2022-06-30 16:45:04 UTC 1.1402 0.4298 1500000
    HAEMONETICS CORP-MASS HAE 2022-06-30 16:15:03 UTC 1.1402 0.4298 1500000
    HAEMONETICS CORP-MASS HAE 2022-06-30 15:45:03 UTC 1.1402 0.4298 1500000
    HAEMONETICS CORP-MASS HAE 2022-06-30 15:15:03 UTC 1.1402 0.4298 1500000
    HAEMONETICS CORP-MASS HAE 2022-06-30 14:45:03 UTC 1.1402 0.4298 1500000
    HAEMONETICS CORP-MASS HAE 2022-06-30 14:15:03 UTC 1.1402 0.4298 1500000
    HAEMONETICS CORP-MASS HAE 2022-06-30 13:45:03 UTC 1.1402 0.4298 1500000
    HAEMONETICS CORP-MASS HAE 2022-06-30 13:15:03 UTC 1.1402 0.4298 1500000
    HAEMONETICS CORP-MASS HAE 2022-06-30 12:45:03 UTC 1.1402 0.4298 1500000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    AGF Investments Trust- AGFIQ U.S. Market Neutral Momentum Fund HAE -204.0 shares, $-24225.0 2020-12-31 N-PORT
    Advisors Series Trust- Pzena Long/Short Value Fund HAE -1286.0 shares, $-141048.48 2020-05-31 N-PORT
    FundVantage Trust- Gotham Master Neutral Fund HAE -23.0 shares, $-2006.75 2020-09-30 N-PORT
    Guidestone Funds- Strategic Alternatives Fund HAE -660.0 shares, $-41725.2 2022-03-31 N-PORT
    AMERICAN BEACON FUNDS- American Beacon SSI Alternative Income Fund HAE -1488.0 shares, $-94071.36 2022-03-31 N-PORT
    First Trust Exchange-Traded Fund III- First Trust Long/Short Equity ETF HAE -6974.0 shares, $-353372.58 2022-04-30 N-PORT
    Morningstar Funds Trust- Morningstar Alternatives Fund HAE -1353.0 shares, $-68556.51 2022-04-29 N-PORT

    Elevate your investments